Trial Of Pembrolizumab And Nintedanib
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Nintedanib
Related studies linked through entity extraction aliases.
Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Ph II Nintedanib vs. Ifosfamide in Soft Tissue Sarcoma
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy and Safety of Nintedanib Co-administered With Sildenafil in Idiopathic Pulmonary Fibrosis Patients With Advanced Lung Function Impairment
- Status
- COMPLETED
- Phase
- PHASE3
Effect of Nintedanib on Biomarkers of Extracellular Matrix Turnover in Patients With Idiopathic Pulmonary Fibrosis and Limited Forced Vital Capacity Impairment
- Status
- COMPLETED
- Phase
- PHASE4
Nintedanib Alone or in Combination With Capecitabine in Refractory Metastatic Colorectal Cancer [LUME-Colon 2]
- Status
- TERMINATED
- Phase
- PHASE2
Investigation of the Effect of Nintedanib on the Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Patients With Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Nintedanib and Weekly Docetaxel in Lung Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Influence of Bosentan on the Pharmacokinetics of Nintedanib
- Status
- COMPLETED
- Phase
- PHASE1
Nintedanib+Letrozole in Postmenopausal Women With Breast Cancer: Clinical Trial Safety and Pharmacodynamics
- Status
- COMPLETED
- Phase
- PHASE1
All-Case Surveillance of Ofev in Patients With IPF in Japan
- Status
- COMPLETED
- Phase
- N/A
A Study to Compare the Amount of Nintedanib and Pirfenidone in the Blood When Nintedanib and Pirfenidone Are Given Separately or in Combination
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Tolerability Study of Pirfenidone in Combination With Nintedanib in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- Status
- COMPLETED
- Phase
- PHASE4
A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis
- Status
- COMPLETED
- Phase
- PHASE3
Safety, Tolerability and PK of Nintedanib in Combination With Pirfenidone in IPF
- Status
- COMPLETED
- Phase
- PHASE4
Relative Bioavailability of 2 Oral Formulations of Nintedanib
- Status
- COMPLETED
- Phase
- PHASE1
Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis
- Status
- COMPLETED
- Phase
- PHASE2
Nintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery and Are Undergoing Chemoradiation Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Nintedanib in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2